Atlas Trials

Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia

Clinical trial NCT03788759 · COMPLETED

Trial details

NCT number
NCT03788759
Sponsor
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
SchizophreniaOxidative Stress
Start date
2019-09-01
Primary completion
2021-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.